A new study finds that in more than 1,000 patients that the administration of metformin in patients suffering from type 2 diabetes led to a change in metabolite levels. According to the authors, this was associated with a significantly decreased level of LDL cholesterol, which is under strong suspicion to promote cardiovascular diseases by causing atherosclerosis. “Our study suggests that metformin might indeed have an additional beneficial effect with regards to cardiovascular diseases among the Diabetes patients,” says first author Dr. Tao Xu. — doi: 10.2337/dc15-0658 Diabetes Care August 5, 2015
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.